Filing Details
- Accession Number:
- 0001104659-18-036324
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-29 13:48:25
- Reporting Period:
- 2018-05-23
- Accepted Time:
- 2018-05-29 13:48:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Plc | NBRV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711517 | Maria Francesco Lavino | 1000 Continental Drive Suite 600 King Of Prussia PA 19406 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-05-23 | 2,160 | $4.60 | 3,719 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction is being reported late due to an administrative oversight.
Billionaire Hedge Funds
